Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov, Shamil Farkhutdinov, Valeriy Petriakov. In vitro analysis of bronchodilators effect on peroxide lipid oxidation. Eur Respir J 2015; 46: Suppl. 59, 1003

Member's Comments

No comment yet.

Related content which might interest you: Prolonged activity where it matters - the reversible esterfication of budesonide improves its topical anti-inflammatory efficacy and selectivity in the airways Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001 Polyphenolic compounds and experimentally induced allergic asthma Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Pharmacological characterization of the anti-oxidant activity of N-acetylcysteine in an ex vivo model of COPD exacerbation Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Advantageous toxicity profile of an inhaled GATA-3-specific DNAzyme intended for anti-inflammatory treatment of Th2-driven asthma Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Enhanced anti-inflammatory gene expression in humans following inhaled budesonide Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Influence of nebulized drugs on ciliary activity in vitro Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Ovalbumin-induced asthma model in Brown Norway rats demonstrates potential anti-asthmatic effects of Neu-164, a novel antioxidant and anti-inflammatory compound Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 Anti-inflammatory effects of aerobic exercise in a murine model of asthma: Role of leukotrienes pathway Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 The antiinflammatory and antioxidant effect of tiotropium bromide in subacute cigarette exposure mouse model Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 In vitro pharmacological characterization of a novel p38α (MAPK14) inhibitor designed for inhaled delivery Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Fast, efficient and realistic in vitro delivery of inhaled drugs to pulmonary cells: Application to the proteasome inhibitor bortezomib Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002 Mucolytics and anti-inflammatory lung treatments Source: ERS course 2015 Year: 2015 Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model Source: International Congress 2015 – New models for treating airway diseases Year: 2015 The mechanisms of anti-inflammatory action of bronchodilators Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma Source: Eur Respir J 2006; 28: 1042-1050 Year: 2006 The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013